Mounjaro
Mounjaro is a brand name for the medication tirzepatide, developed by Eli Lilly. It is an injectable medication used for the treatment of type 2 diabetes and has gained attention for its effectiveness in lowering blood sugar levels and promoting weight loss, making it a popular choice among patients.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| Italy | 1 | 7.00 | 0.04% | +0% | 60,461,826 | 22,460 | $2,000,000 | 743$ |
| Totals | 1 | 60,461,826 | 22,460 | $2,000,000 | 743$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Italy:
Mounjaro is a popular injectable drug that Eli Lilly's Orforglipron is compared to.
7